Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding [Phase 2]
Phase 2 dose tolerability/dose-range finding study of SUBLIVAC FIX Birch has completed, evaluating tolerability across multiple doses in all…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis [Phase 2]
Phase 2 dose-range finding study update for PURETHAL mites in patients with persistent allergic rhinitis or rhinoconjunctivitis; the trial (…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: SUBLIVAC FIX Phleum Pratense DT/DRF [Phase 2]
Phase 2 trial of SUBLIVAC FIX Phleum Pratense DT/DRF has completed, evaluating its use for allergic rhinitis and allergic rhinoconjunctiviti…
-
FDA approval · 2013-05-28FDA Approved: CHILDRENS CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Children's Cetirizine Hydrochloride from Sun Pharmaceutical Industries, Inc. This action exp…
-
FDA approval · 2013-05-24FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) from Chattem, expanding its labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Safety and Efficacy of AL-53817 Nasal Spray Solution [Phase 1]
A Phase 1 clinical trial evaluated the safety and efficacy of AL-53817 nasal spray for nasal allergies; results were completed and posted in…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Is There a Comorbidity Between Migraine and Allergic Rhinitis?
A completed Baskent University clinical trial examined whether migraine and allergic rhinitis are comorbid conditions and if one may influen…
-
CLINICAL_TRIALS trial_result · 2013-04-30Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy [Phase 2, Phase 3]
An open Phase 2/3 trial assessing the tolerability of AVANZ Olive Immunotherapy in allergic rhinitis due to olive pollen has completed.
-
FDA approval · 2013-04-28FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., related to its use i…
-
FDA approval · 2013-04-26FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) submitted by Bayer HealthCare LL…
-
FDA approval · 2013-04-04FDA Approved: CROMOLYN SODIUM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for cromolyn sodium.
-
FDA approval · 2013-03-26FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer's supplemental application to add a Claritin chewable grape and bubblegum formulation containing loratadine. This exp…
-
FDA approval · 2013-03-26FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) filed by Viatris Specialty LLC…
-
FDA label_change · 2013-03-22FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Omnaris (ciclesonide) from Covis Pharma US, Inc., resulting in changes to the product’s labe…
-
FDA label_change · 2013-03-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC, resulting in a labeling change for the product.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of BLX-028914 in subjects with allergic rhinitis.
-
FDA approval · 2013-03-13FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour, a combination of loratadine and pseudoephedrine sulfate.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
A completed clinical trial evaluated the sensitivity and specificity of a nasal provocation test for house dust mite–triggered allergic rhin…
-
FDA approval · 2013-03-13FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for azelastine hydrochloride from Apotex Corp., as indicated by the FDA's 'AP' submission status for…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a biomarker-based cockroach sublingual immunotherapy (BioCSI) for allergic rhinitis and asthma complet…
-
CLINICAL_TRIALS research · 2013-03-01Clinical Trial Update: Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.
A clinical trial update evaluating immunological changes and clinical efficacy of Der p house dust mite allergen immunotherapy in monosensit…
-
FDA approval · 2013-02-28FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer HealthCare LLC's supplemental application for Claritin Allergy (loratadine). This action covers changes related to th…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis
This clinical trial update describes the development of allergic rhinitis in children previously diagnosed with nonallergic rhinitis; the st…
-
FDA approval · 2013-02-13FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy [Phase 4]
Phase 4 trial update on immunological outcomes of sublingual immunotherapy for house dust mite allergy in people with allergic rhinitis and …